Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

270.28 USD UNCHANGED
Streaming Delayed Price Updated: 5:19 PM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 270.28
Bid (Size) 269.90 (1)
Ask (Size) 271.00 (1)
Prev. Close 270.28
Today's Range 270.28 - 270.28
52wk Range 223.25 - 374.99
Shares Outstanding 211,007,945
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Biogen Inc. ("Biogen" or "the Company") (NASDAQ: BIIB) for violations of... 
From PR Newswire
DEADLINE ALERT for TILE, BABA, and BIIB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases

Performance

YTD
+11.25%
+11.25%
1 Month
+8.84%
+8.84%
3 Month
+0.51%
+0.51%
6 Month
-3.75%
-3.75%
1 Year
-5.89%
-5.89%

More News

Read More
Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors
From GlobeNewswire News Releases
Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone
From GlobeNewswire News Releases
LAWSUITS FILED AGAINST BIIB, SPLK and QSR - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
From ACCESSWIRE
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Noteworthy Wednesday Option Activity: F, MS, BIIB
Tags Stocks
From Market News Video
Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases
From Business Wire News Releases
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
Tags Benzinga TLRY CRON
From Benzinga
Should Biotech Investors Buy Stocks Before Binary Events?
Tags BIIB Market News
From Motley Fool
Why Eli Lilly, Exact Sciences, Biogen Are Trading Higher Today
Tags Benzinga why it's moving LLY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.